Eversept Partners, LP

Q4 2021 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Ron Rosenstraus - Chief Financial Officer
Location
New York, NY
Holdings as of
31 Dec 2021
Value $
$1.2B
Num holdings
90
Date filed
08 Nov 2023, 14:31
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included HZNP, CYH, UTHR, DHR, and AZN.
Previous filing
Q3 2021 - 08 Nov 2023
Next filing
Q1 2022 - 08 Nov 2023
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q4 - Restatement compared to 2021 Q3 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ron Rosenstraus Chief Financial Officer New York, New York 08 Nov 2023

Eversept Partners, LP ("Eversept") is filing this amendment primarily to correct our previous reporting of put and call option positions. In the Information Table in all reports on Form 13F filed from the fourth quarter of 2017 through the second quarter of 2023, Eversept had erroneously provided the requested information in columns 2-5 of the Information Table with respect to the put and call options themselves, rather than with respect to the securities underlying the options.